Patient and Physician Behavior
Other featured articles
Prescription Opioid Use in General and Pediatric Emergency Departments
Children, adolescents, and young adults treated in pediatric emergency departments are much less likely to be prescribed opioids compared to patients of similar age and ailment treated at general EDs.
Extended-Release Formulation and Medication Adherence
Suboptimal adherence to chronic medications undermines treatment effectiveness and costs the U.S. as much as $289 billion annually. This is the first study to analyze the impact of extended-release formulations on long-term adherence.
Opioid Prescribing Decreases After Learning of a Patient’s Fatal Overdose
Results of the randomized trial show opioid prescribing decreases after a clinician learns of a patient’s fatal overdose.
It’s Time to Let Pharmacists Prescribe COVID-Fighting Pills Like Paxlovid
To reduce hospitalization and death, pharmacists should have the same prescribing abilities as doctors for COVID anti-viral drugs Paxlovid and Lagevrio, USC School of Pharmacy
Dean Vassilios Papadopoulos writes in a new MarketWatch op-ed.
About this section
Patients as well as providers must take responsibility in improving healthcare, but human fallibility can impede success. The Schaeffer Center fosters supportive and effective ways to improve the decision-making of all parties for healthier results.